Neuronal differentiation in human neuroblastoma cells by nerve growth factor following TrkA up-regulation by interferon-gamma

Med Pediatr Oncol. 2000 Jun;34(6):394-401. doi: 10.1002/(sici)1096-911x(200006)34:6<394::aid-mpo3>3.0.co;2-5.

Abstract

Background: TrkA mRNA expression has been reported to be related to favorable outcome of neuroblastoma (NB). Previously, we found that interferon-gamma (IFN-gamma) can enhance TrkA mRNA expression in NB cell lines. In the present study, we examined the effect of nerve growth factor (NGF) on IFN-gamma-induced TrkA protein to clarify the relationship between TrkA and cell differentiation of NB.

Procedure: The effect of IFN-gamma on the TrkA mRNA expression was screened in six human NB cell lines and a freshly prepared sample, SK-rib, from a stage IV patient. Using two of them, we examined their morphological change during simultaneous loading of NGF and IFN-gamma. Tyrosine phosphorylation pattern after 5 min of NGF stimulation was also examined in immunoblot analysis with anti-gp140(trkA) antibody and antiphospho tyrosine antibody.

Results: After a 4-day treatment with 500 IU/ml IFN-gamma, TrkA mRNA increased in five cell lines and SK-rib cells in association with growth inhibition. Although the degree of morphological differentiation did not increase in proportion to the TrkA expression induced by IFN-gamma, continuous loading of both IFN-gamma and NGF caused marked morphological differentiation in a cultured KP-N-RT cell line and SK-rib cells during 10 days. Moreover, 5 min of NGF stimulation after IFN-gamma treatment caused the phosphorylation of TrkA protein and downstream proteins.

Conclusions: IFN-gamma could induce the functional NGF receptor even in the aggressive phenotype of NB.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Immunoblotting
  • Interferon-gamma / pharmacology*
  • Nerve Growth Factor / metabolism*
  • Neuroblastoma / drug therapy*
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology*
  • Phosphorylation / drug effects
  • Precipitin Tests
  • Proto-Oncogene Proteins c-myc / biosynthesis
  • RNA, Messenger / drug effects
  • RNA, Neoplasm / drug effects
  • Receptor, trkA / biosynthesis*
  • Receptor, trkA / drug effects*
  • Receptor, trkA / genetics
  • Tumor Cells, Cultured
  • Tyrosine / metabolism
  • Up-Regulation / drug effects

Substances

  • Antineoplastic Agents
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • RNA, Neoplasm
  • Tyrosine
  • Interferon-gamma
  • Nerve Growth Factor
  • Receptor, trkA